Serial #90083614
DEAD

Serial Number

90083614

Owner

BeiGene, Ltd.

Attorney

Kristen S. Ruisi

Filing Date

Jul 30, 2020

Add to watchlist:

No watchlists yet
View on USPTO

Serial #90083614 Trademark

Serial Number: 90083614

Serial #90083614 is a trademark filed by BeiGene, Ltd. on July 30, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

BeiGene, Ltd. (84 trademarks)

San Mateo, CA 94404

Entity Type: 99

Trademark Details

Filing Date

July 30, 2020

Registration Date

Not Registered

Published for Opposition

February 23, 2021

Goods & Services

Custom manufacturing services in the nature of chemical processing and production of medicines and pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases

Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude drugs in the nature of pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Biochemical preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases

Advertising services; personnel management consultancy; accounting services; business management assistance; sponsorship search; Retail or wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; marketing services; provision of an on-line marketplace for buyers and sellers of goods and services; systemization of information into computer databases

Telemedicine services; health care; convalescent home services; beauty salon services; physical therapy services; gardening; veterinary services; health counseling; pharmacy advice, namely, pharmaceutical advice; rental of sanitary installations

Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, tracking; packaging design

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Nov 21, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 21, 2022 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 7, 2022 EXRA
SOU EXTENSION 2 GRANTED
Apr 5, 2022 EX2G
SOU EXTENSION 2 FILED
Apr 5, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 5, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 20, 2021 EXRA
SOU EXTENSION 1 GRANTED
Oct 18, 2021 EX1G
SOU EXTENSION 1 FILED
Oct 18, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 18, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 20, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 23, 2021 NPUB
PUBLISHED FOR OPPOSITION
Feb 23, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 3, 2021 NONP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 28, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 28, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 28, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 28, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 28, 2021 COAR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 15, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 15, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 15, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 15, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 15, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 6, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 6, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 6, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 6, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 6, 2020 GNRT
NON-FINAL ACTION WRITTEN
Nov 6, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 5, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 29, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 28, 2020 NWOS
NEW APPLICATION ENTERED
Aug 3, 2020 NWAP